SCHEMBL5218735

SCHEMBL5218735

CC(C)(C)OC(=O)COC/C=C\COC1CCCOC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5218740 0.79 MEN1 (0.35)
SCHEMBL5218731 0.79 MEN1 (0.35)
SCHEMBL18294545 0.79 MEN1 (0.35)
SCHEMBL24671886 0.76 ATF4 (0.38)
SCHEMBL29059882 0.76 ATF4 (0.38)
SCHEMBL5211003 0.69 PTGS1 (0.34)
SCHEMBL5210998 0.69 PTGS1 (0.34)
SCHEMBL9180517 0.68
SCHEMBL5211968 0.68 PTGS1 (0.33)
SCHEMBL5211959 0.68 PTGS1 (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7205302-B2 Anticoagulants; antilipemic agents; cardiovascular disorders NIPPON SHINYAKU CO., LTD. (JP) 2007-04-17 US disclosed
EP-1400518-B1 HETEROCYCLIC COMPOUND DERIVATIVES AND MEDICINES NIPPON SHINYAKU CO LTD (JP) 2007-01-17 EP disclosed
US-20040102436-A1 Heterocyclic compound derivatives and medicines NIPPON SHINYAKU CO., LTD. (JP) 2004-05-27 US disclosed
EP-1400518-A1 HETEROCYCLIC COMPOUND DERIVATIVES AND MEDICINES Nippon Shinyaku Co., Ltd. (JP) 2004-03-24 EP disclosed